Hydroxyapatite Market 2022 Expectations & Growth Trends Highlighted Until 2030

Calcium phosphate, most commonly known as hydroxyapatite, is used as a bio active material, which interacts with tissues and also aids bone growth. It accounts for a relatively smaller share in the current scenario; however, it is expected to expand significantly over the forecast period. It is mostly applied as coatings over the conventionally-used titanium or stainless steel implants and are projected to play an important role in 3-D printing over the coming years. From medical research it has been found that the natural human bone comprises of 70% hydroxyapatite.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12308

“In recent years, with the advent of 3D printing and use of biomaterials for prosthetics and implants, hydroxyapatite has continued to gain prominence in its use as a biomaterial. Moreover, with increased spending on healthcare devices and treatment, the  market participants will benefit from adding a good value proposition” says the FMI analyst.

Key Takeaways of Hydroxyapatite Study

• In terms of application, orthopedic implants are projected to hold a significant share in the global hydroxyapatite market owing to an increase in the number of knee, hip and joint replacement cases due to several factors such as the increasing aging population, accident and physical trauma, etc.
• China and North America are expected to be the most promising regions in terms of product sales. Collectively, both regions are estimated to hold over half of the market share, in terms of value, during the forecast period
• The global market for hydroxyapatite is fairly competitive, with consolidation primarily between the  top 3 manufacturers
• Key players in the market are focusing on product development as well as mergers and acquisitions to strengthen their business footprint in domestic and overseas market. Pre-emptive strategy has proven to be a key differentiator

In spite of the COVID-19 pandemic and the resultant lockdown on manufacturing, the perceived growth trend will continue to be unhindered. Though, in the initial months of 2020, the immediate lockdown will affect the production, supply and sales process, yet from the consistent demand from critical medical cases and required prosthetics, the demand of hydroxyapatite as the principal material would be sustained in the successive years. The global hydroxyapatite market is expected to witness a rebound during the first and second quarters of 2021.

Hydroxyapatite Market: Region-wise Analysis

North America is estimated close in at 35% of the hydroxyapatite market value share, accounting for a prominent weightage during the forecast period. Asia Pacific is another prominent region whose growth rate is expected to leapfrog over other regions in the forecast period.

China and South East Asia are estimated to hold a prominent market share in terms of consumption of Hydroxyapatite.

Demand from North America and Europe is largely attributable to treatment of geriatric population, prosthetic implants for professional purposes, whereas, the demand from Asia Pacific and other countries are due to surging accident and trauma related cases and commercial development of the product.

It can also be reasoned that developed countries have been the early adopters whereas the developing countries are in the introductory stage of product adoption.

Hydroxyapatite Market: The Way Forward

• Over the forecast period, Hydroxyapatite market is expected to witness a healthy growth of around 9% throughout the forecast period
• Investments to explore and expand the application areas for hydroxyapatite are projected to boost demand for research grade
• Orthopaedic implants are projected to witness growing demand for hydroxyapatite for coating applications whereas dental implants are projected to witness significant growth in the latter half of the forecast period
• Having a strong product base and establishment of business footprint across regional markets have been the governing benchmark of the leading players of hydroxyapatite market.

Competitive Landscape:

Fluidinova, Bonesupport AB, Berkeley Advanced Biomaterials, Sigma Graft, Nano Interface Technology, SofSera, Plasma Biotal Ltd., and Premier Biomaterials are considered as some of the leading market players in the Hydroxyapatite market. The top 3-4 manufacturers hold around half of the global market share in which these players are adopting inorganic growth strategies for the business development. Key players such as Bone support AB and Berkeley Advanced Biomaterials are focused on collaboration and acquisition to expand their presence in the global market.